Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam - PRNewswire
Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam PRNewswire
from "acne" - Google News https://ift.tt/2r2VMyO
from "acne" - Google News https://ift.tt/2r2VMyO
Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam - PRNewswire
![Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam - PRNewswire]()
Reviewed by Admin
on
November 18, 2019
Rating:
No comments: